Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER

Name: Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
SKU: 4254
Availability: InStock

$0.00

Letter to the Editor

AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 41 No. 2 Articles Tags: branimir-margetic, letter-to-the-editor, obsessive-compulsive-disorder

Description

Description

Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER PB-41-2-03-Margeti_Letter

Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER

Description

Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients

Zolpidem Stimulant Effect and Dependence: A Case Report on Intranasal Use

Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety

Paul A. Cannistraro, MD: Neural Circuitry of Anxiety: Evidence from Structural and Functional Neuroimaging Studies

Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER

Description

Related products

Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients

Zolpidem Stimulant Effect and Dependence: A Case Report on Intranasal Use

Neurobiology and Mechanisms of Antidepressant Treatment Response in Anxiety

Paul A. Cannistraro, MD: Neural Circuitry of Anxiety: Evidence from Structural and Functional Neuroimaging Studies